UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): August 13, 2009
CARDIOGENESIS CORPORATION
(Exact name of registrant as specified in its charter)
| |
|
|
|
|
| California
|
|
000-28288
|
|
77-0223740 |
(State or other jurisdiction
of incorporation)
|
|
(Commission File Number)
|
|
(IRS Employer
Identification No.) |
11 Musick
Irvine, CA 92618
(Address of principal executive offices, including zip code)
Registrant’s telephone number, including area code: (949) 420-1800
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under
the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under
the Exchange Act (17 CFR 240.13e-4(c))
TABLE OF CONTENTS
Item 2.02 Results of Operation and Financial Condition
On August 13, 2009, Cardiogenesis Corporation (the “Company”) issued a press release announcing its
financial results for the quarter ended June 30, 2009. The press release is furnished as Exhibit
99.1 and is incorporated herein by reference.
Also on August 13, 2009, the Company held a conference call with analysts and investors to report
its financial results for the quarter ended June 30, 2009. The transcript of the conference call is
furnished as Exhibit 99.2 and is incorporated herein by reference.
The information in this Form 8-K, including Exhibits 99.1 and 99.2, are furnished pursuant to Item
2.02 and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of
1934, nor shall they be deemed incorporated by reference in any filing under the Securities Act of
1933, except as shall be expressly set forth by specific reference in such filing.
Item 9.01 Financial Statements and Exhibits
(d) Exhibits
| |
|
|
| Exhibit Number |
|
Description |
|
|
|
99.1
|
|
Press release of Cardiogenesis Corporation dated August 13,
2009. |
99.2
|
|
Conference Call Transcript dated August 13, 2009. |